New Jersey CEO pleads guilty to $212 million investor fraud scheme tied to healthcare company
NEWARK, N.J. – The former CEO of a publicly traded healthcare services firm pleaded guilty to conspiracy to commit securities fraud in a scheme that defrauded investors out of hundreds…